Endoscopy 2019; 51(11): 1027-1034
DOI: 10.1055/a-0865-1960
Original article
© Georg Thieme Verlag KG Stuttgart · New York

Prophylactic pancreatic duct stenting in severe acute necrotizing pancreatitis: a prospective randomized study

Heikki Karjula
1   Department of Surgery, Oulu University Hospital, Oulu, Finland
,
Palle Nordblad Schmidt
2   Department of Gastroenterology and Gastrointestinal Surgery, Hvidovre Hospital, Copenhagen, Denmark
,
Jyrki Mäkelä
1   Department of Surgery, Oulu University Hospital, Oulu, Finland
,
Janne H. Liisanantti
3   Department of Anesthesiology, Division of Intensive Care Medicine, Oulu University Hospital, Oulu, Finland
,
Pasi Ohtonen
1   Department of Surgery, Oulu University Hospital, Oulu, Finland
,
Arto Saarela
1   Department of Surgery, Oulu University Hospital, Oulu, Finland
› Author Affiliations
TRIAL REGISTRATION: Multi-center, randomized, prospective trial NCT01767233 at clinicaltrials.gov
Further Information

Publication History

submitted 01 June 2018

accepted after revision 05 February 2019

Publication Date:
20 March 2019 (online)

Abstract

Background Pancreatic duct disruption is common and is associated with high morbidity in cases of acute necrotizing pancreatitis (ANP). In this study, we tested the feasibility and safety of prophylactic pancreatic duct stenting (PPDS) in ANP and compared PPDS with conservative treatment.

Methods We prospectively enrolled patients (aged 18 – 75 years) diagnosed with ANP between February 2011 and July 2015. These patients were prospectively randomized to receive PPDS or conservative treatment at two tertiary centers. PPDS was performed as soon as possible after randomization.

Results Concern regarding iatrogenic infections with pancreatic necrosis in the PPDS group prompted interim analysis, which confirmed a highly elevated risk. Thus, the trial was terminated prematurely for ethical reasons. Of the 11 patients in the PPDS group, all patients with successful pancreatic duct placement (5/5, 100 %) presented with infection, compared with only 3 of the 13 patients (23.1 %) in the conservative treatment group (P = 0.01). Analysis revealed success rates of 63.6 % for pancreatic duct cannulation, 45.5 % for pancreatic duct stenting, and 18.2 % for placement of a stent bridging the necrosis. Cannulation and stenting failures were due to duodenal edema and pancreatic duct stenosis.

Conclusions PPDS in ANP is associated with an unacceptably high risk of pancreatic necrosis infection. In addition, the procedure is technically challenging due to duodenal edema and ductal stenosis.

Supplementary material, Table 1s

 
  • References

  • 1 Lau ST, Simchuk EJ, Kozarek RA. et al. A pancreatic ductal leak should be sought to direct treatment in patients with acute pancreatitis. Am J Surg 2001; 181: 411-415
  • 2 Neoptolemos JP, London NJ, Carr-Locke DL. Assessment of main pancreatic duct integrity by endoscopic retrograde pancreatography in patients with acute pancreatitis. Br J Surg 1993; 80: 94-99
  • 3 Karjula H, Saarela A, Vaarala A. et al. Endoscopic transpapillary stenting for pancreatic fistulas after necrosectomy with necrotizing pancreatitis. Surg Endosc 2015; 29: 108-112
  • 4 Nealon WH, Bhutani M, Riall TS. et al. A unifying concept: Pancreatic ductal anatomy both predicts and determines the major complications resulting from pancreatitis. J Am Coll Surg 2009; 208: 790-799
  • 5 Telford JJ, Farrell JJ, Saltzman JR. et al. Pancreatic stent placement for duct disruption. Gastrointest Endosc 2002; 56: 18-24
  • 6 Varadarajulu S, Rana SS, Bhasin DK. Endoscopic therapy for pancreatic duct leaks and disruptions. Gastrointest Endosc Clin N Am 2013; 23: 863-892
  • 7 Jang JW, Kim MH, Oh D. et al. Factors and outcomes associated with pancreatic duct disruption in patients with acute necrotizing pancreatitis. Pancreatology 2016; 16: 958-965
  • 8 Kozarek RA, Attia FM, Traverso LW. et al. Pacreatic duct leak in necrotizing pancreatitis: role of diagnostic and therapeutic ERCP as part of a multidisciplinary approach. Gastrointest Endosc 2000; 51: A138
  • 9 Larsen M, Kozarek R. Management of pancreatic ductal leaks and fistulae. J Gastroenterol Hepatol 2014; 29: 1360-1370
  • 10 Working Group IAP/APA Acute Pancreatitis Guidelines. IAP/APA evidence-based guidelines for the management of acute pancreatitis. Pancreatology 2013; 13 (Suppl. 02) e1-15
  • 11 Uomo G, Molino D, Visconti M. et al. The incidence of main pancreatic duct disruption in severe biliary pancreatitis. Am J Surg 1998; 176: 49-52
  • 12 Bakker OJ, van Baal MC, van Santvoort HC. et al. Endoscopic transpapillary stenting or conservative treatment for pancreatic fistulas in necrotizing pancreatitis: multicenter series and literature review. Ann Surg 2011; 253: 961-967
  • 13 Fischer TD, Gutman DS, Hughes SJ. et al. Disconnected pancreatic duct syndrome: disease classification and management strategies. J Am Coll Surg 2014; 219: 704-712
  • 14 Kozarek RA. Endoscopic management of pancreatic necrosis: not for the uncommitted. Gastrointest Endosc 2005; 62: 101-104
  • 15 Halttunen J, Weckman L, Kemppainen E. et al. The endoscopic management of pancreatic fistulas. Surg Endosc 2005; 19: 559-562
  • 16 Boerma D, Rauws EA, van Gulik TM. et al. Endoscopic stent placement for pancreaticocutaneous fistula after surgical drainage of the pancreas. Br J Surg 2000; 87: 1506-1509
  • 17 Kozarek RA, Ball TJ, Patterson DJ. et al. Transpapillary stenting for pancreaticocutaneous fistulas. J Gastrointest Surg 1997; 1: 357-361
  • 18 Yokoi Y, Kikuyama M, Kurokami T. et al. Early dual drainage combining transpapillary endotherapy and percutaneous catheter drainage in patients with pancreatic fistula associated with severe acute pancreatitis. Pancreatology 2016; 16: 497-507
  • 19 Canlas KR, Branch MS. Role of endoscopic retrograde cholangiopancreatography in acute pancreatitis. World J Gastroenterol 2007; 13: 6314-6320
  • 20 Dubravcsik Z, Hritz I, Fejes R. et al. Early ERCP and biliary sphincterotomy with or without small-caliber pancreatic stent insertion in patients with acute biliary pancreatitis: better overall outcome with adequate pancreatic drainage. Scand J Gastroenterol 2012; 47: 729-736
  • 21 Freeman ML. Pancreatic stents for prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis. Clin Gastroenterol Hepatol 2007; 5: 1354-1365
  • 22 Kerdsirichairat T, Attam R, Arain M. et al. Urgent ERCP with pancreatic stent placement or replacement for salvage of post-ERCP pancreatitis. Endoscopy 2014; 46: 1085-1094
  • 23 Madácsy L, Kurucsai G, Joó I. et al. Rescue ERCP and insertion of a small-caliber pancreatic stent to prevent the evolution of severe post-ERCP pancreatitis: a case-controlled series. Surg Endosc 2009; 23: 1887-1893
  • 24 Kochar B, Akshintala VS, Afghani E. et al. Incidence, severity, and mortality of post-ERCP pancreatitis: a systematic review by using randomized, controlled trials. Gastrointest Endosc 2015; 81: 143-149
  • 25 Zuidema GD, Yeo CJ. eds. Shackelford’s surgery of the alimentary tract. Volume 3. 5th edn. London: WB Saunders; 2001
  • 26 Umapathy C, Raina A, Saligram S. et al. Natural history after acute necrotizing pancreatitis: a large US tertiary care experience. J Gastrointest Surg 2016; 20: 1844-1853